(Q43484203)

English

Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects

scientific article published in May 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Weber DJ

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Tolkoff-Rubin NE

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Rubin RH

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

1 May 1984

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

122-136

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Diagnosis and treatment: drugs five years later. Amoxicillin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

The inhibition of staphylococcal β-lactamase by clavulanic acid

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Clavulanic Acid, a Novel Inhibitor of β-Lactamases

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Comparative clinical pharmacology of amoxicillin and ampicillin administered orally

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Pharmacokinetics of Bacampicillin Compared with Those of Ampicillin, Pivampicillin, and Amoxycillin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Pharmacokinetics of Amoxicillin and Ampicillin: Crossover Study of the Effect of Food

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

In vitro-activity of clavulanic acid and amoxicillin combined against amoxicillin-resistant bacteria

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Inhibition of β-Lactamase in Neisseria gonorrhoeae by Sodium Clavulanate

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

The Influence of clavulanic acid on the susceptibility to amoxycillin of β-lactamase producing strains of H. influenzae using different inoculum sizes

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Effect of clavulanic acid and amoxycillin formulation against β-lactamase producing Gram-negative bacteria in urinary tract infections

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Activities of amoxicillin and clavulanic acid combinations against urinary tract infections

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Effect of Clavulanic Acid on the In Vitro Synergism Between Carbenicillin and Gentamicin Against Serratia marcescens

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1984.TB03333.X

21 January 2018

Identifiers

10.1002/J.1875-9114.1984.TB03333.X

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43484203&oldid=2143596454"